A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · see citing works

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · see citing works

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works

Reduced Prefrontal Glutamate/Glutamine and γ-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance Spectroscopy

Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846 · see citing works

Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression

Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · see citing works

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · see citing works

A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus

Tang, S. J., Reis, G., Kang, H., Gingras, A.-C., Sonenberg, N., & Schuman, E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012605299 · Cited by 734 · see citing works

Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · see citing works

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 562 · see citing works

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553 · see citing works

Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression

Hou, L., & Klann, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0995-04.2004 · Cited by 527 · see citing works

Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [¹¹C]DASB Positron Emission Tomography Study

Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · see citing works

Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT

Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Berman, R., & Krystal, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.577 · Cited by 512 · see citing works

Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.

Rothman, D. L., Petroff, O. A. C., Behar, K. L., & Mattson, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5662 · Cited by 510 · see citing works

Increased Occipital Cortex GABA Concentrations in Depressed Patients After Therapy With Selective Serotonin Reuptake Inhibitors

Sanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 495 · see citing works

Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

Awad, H., Hubert, G. W., Smith, Y., Levey, A. I., & Conn, P. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07871.2000 · Cited by 423 · see citing works

Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression

Cryan, J. F., & Kaupmann, K. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.004 · Cited by 421 · see citing works

Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression

Sequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388 · see citing works

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder

Jernigan, C. S., Goswami, D. B., Austin, M. C., Iyo, A. H., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.010 · Cited by 386 · see citing works

GABA and mood disorders: a brief review and hypothesis

Petty, F. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00025-i · Cited by 378 · see citing works

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

McGirr, A., Berlim, M. T., Bond, D. J., Fleck, M. P., Yatham, L. N., & Lam, R. W. (2015) · Psychological Medicine · doi:10.1017/s0033291714001603 · Cited by 373 · see citing works

Antidepressants for the new millennium.

Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 372 · see citing works

Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression

Boldrini, M., Santiago, A. N., Hen, R., Dwork, A. J., Rosoklija, G. B., Tamir, H., Arango, V., & John Mann, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.5 · Cited by 361 · see citing works

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346 · see citing works

Ketamine administration in depressive disorders: a systematic review and meta-analysis

Fond, G., Loundou, A., Rabu, C., Macgregor, A., Lançon, C., Brittner, M., Micoulaud-Franchi, J.-A., Richieri, R., Courtet, P., Abbar, M., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3664-5 · Cited by 339 · see citing works

Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1

Cammalleri, M., Lütjens, R., Berton, F., King, A. R., Simpson, C., Francesconi, W., & Sanna, P. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2336098100 · Cited by 314 · see citing works

Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study

Rowland, L. M., Bustillo, J. R., Mullins, P. G., Jung, R. E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., & Brooks, W. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.394 · Cited by 304 · see citing works

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295 · see citing works

Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons

Lauterborn, J. C., LYNCH, G. S., Vanderklish, P. W., Arai, A., & Gall, C. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00008.2000 · Cited by 291 · see citing works

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

Papp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272 · see citing works

Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder

Price, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.025 · Cited by 270 · see citing works

GABA levels in CSF of patients with psychiatric disorders

Gold, B. I., Bowers, M. B., Roth, R. H., & Sweeney, D. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.3.362 · Cited by 270 · see citing works

Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder

Levinson, A. J., Fitzgerald, P. B., Favalli, G., Blumberger, D. M., Daigle, M., & Daskalakis, Z. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.025 · Cited by 261 · see citing works

Sex differences in the antidepressant-like effects of ketamine

Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251 · see citing works

Proc. Intl. Soc. Magn. Reson. Med

Beqiri, A., Padormo, F., Hand, J. W., Hajnal, J. V., & Malik, S. (2014) · Cited by 238 · see citing works

Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake Inhibitor

Bhagwagar, Z., Wylezinska, M., Taylor, M. J., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.368 · Cited by 227 · see citing works

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00194-5 · Cited by 225 · see citing works

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

Shiroma, P. R., Johns, B., Kuskowski, M. A., Wels, J., THURAS, P. D., Albott, C. S., & Lim, K. O. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.036 · Cited by 222 · see citing works

Pharmacological validation of the chronic mild stress model of depression

Papp, M., Moryl, E., & Willner, P. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00697-4 · Cited by 205 · see citing works

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

Valentine, G. W., Mason, G. F., Gomez, R., Fasula, M. K., Watzl, J., Pittman, B. P., Krystal, J. H., & Sanacora, G. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.009 · Cited by 205 · see citing works

Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism

Hettema, J. M., An, S., Neale, M. C., Bukszár, J., van den Oord, E. J. C. G., Kendler, K. S., & Chen, X. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001845 · Cited by 175 · see citing works

Basic neurochemistry : principles of molecular, cellular and medical neurobiology

Brady, S. T., Siegel, G. J., Albers, R. W., & Price, D. L. (2012) · Cited by 171 · see citing works

Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging Studies

Maciąg, D., Hughes, J., O'Dwyer, G., Pride, Y., Stockmeier, C. A., Sanacora, G., & Rajkowska, G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.027 · Cited by 170 · see citing works

Antidepressant-like properties of zinc in rodent forced swim test

Kroczka, B., Brański, P., Pałucha-Poniewiera, A., Pilc, A., & Nowak, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00473-7 · Cited by 161 · see citing works

Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus

Bai, F., Bergeron, M., & Nelson, D. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00104-7 · Cited by 144 · see citing works

Is subcortical–cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach

Alcaro, A., Panksepp, J., Witczak, J., Hayes, D. J., & Northoff, G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.023 · Cited by 144 · see citing works

Effects of MK-801 and antidepressant drugs in the forced swimming test in rats

Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90034-6 · Cited by 141 · see citing works

Glutamatergic Regulation of the p70S6 Kinase in Primary Mouse Neurons*

Lenz, G., & Avruch, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500363200 · Cited by 140 · see citing works

Increased Vertical Axon Numbers in Cingulate Cortex of Schizophrenics

Benes, F. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230097015 · Cited by 140 · see citing works

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

Layer, R. T., Popik, P., Olds, T., & Skolnick, P. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00155-p · Cited by 137 · see citing works

Erratum: Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism

Hettema, J. M., An, S., Neale, M. C., Bukszár, J., van den Oord, E. J. C. G., Kendler, K. S., & Chen, X.-X. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001858 · Cited by 137 · see citing works

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

Pałucha-Poniewiera, A., Brański, P., Szewczyk, B., Wierońska, J. M., Kłak, K., & Pilc, A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.015 · Cited by 135 · see citing works

Brain-Derived Neurotrophic Factor and Basic Fibroblast Growth Factor Downregulate NMDA Receptor Function in Cerebellar Granule Cells

Brandoli, C., Sanna, A., Bernardi, M. A. D., Follesa, P., Brooker, G., & Mocchetti, I. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07953.1998 · Cited by 131 · see citing works

GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action

Sanacora, G., & Sarıçiçek, A. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363294 · Cited by 131 · see citing works

1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism

Chowdhury, G. M. I., Behar, K. L., Cho, W., Thomas, M. A., Rothman, D. L., & Sanacora, G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.006 · Cited by 125 · see citing works

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study

Maćkowiak, M., O’Neill, M. J., Hicks, C. A., Bleakman, D., & Skolnick, P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00066-7 · Cited by 125 · see citing works

Rapamycin‐sensitive signalling in long‐term consolidation of auditory cortex‐dependent memory

Tischmeyer, W., Schicknick, H., Kraus, M., Seidenbecher, C., Staak, S., Scheich, H., & Gundelfinger, E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02820.x · Cited by 124 · see citing works

Normal Prefrontal Gamma-Aminobutyric Acid Levels in Remitted Depressed Subjects Determined by Proton Magnetic Resonance Spectroscopy

Hasler, G., Neumeister, A., van der Veen, J. W. C., Tumonis, T., Bain, E., Shen, J., Drevets, W. C., & Charney, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.017 · Cited by 122 · see citing works

Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury

Smith, D. H., Okiyama, K., Gennarelli, T. A., & McIntosh, T. K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90739-8 · Cited by 114 · see citing works

Antidepressant-like Effects of a Partial Agonist at Strychnine-insensitive Glycine Receptors and a Competitive NMDA Receptor Antagonist

Przegaliński, E., Tatarczynska, E., Dereń-Wesołek, A., & Chojnacka-Wójcik, E. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00157-8 · Cited by 111 · see citing works

Magnesium and depression: A systematic review

Derom, M.-L., Sayón-Orea, C., Martínez-Ortega, J. M., & Martínez-González, M. A. (2013) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000044 · Cited by 108 · see citing works

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator

Legutko, B., Li, X., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00006-5 · Cited by 106 · see citing works

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Zarate, C. A., Quiroz, J. A., Quiroz, J. A., Manji, H. K., Payne, J. L., Kornstein, S. G., Manji, A. H. K., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4204 · Cited by 104 · see citing works

Protein synthesis‐dependent LTP in isolated dendrites of CA1 pyramidal cells

Cracco, J., Serrano, P., Moskowitz, S. I., Bergold, P., & Sacktor, T. (2005) · Hippocampus · doi:10.1002/hipo.20078 · Cited by 101 · see citing works

Neuron density and serotonin receptor binding in prefrontal cortex in suicide

Underwood, M. D., Kassir, S. A., Bakalian, M. J., Galfalvy, H., Mann, J. J., & Arango, V. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000691 · Cited by 100 · see citing works

Proton Magnetic Resonance Spectroscopy of the Motor Cortex in 70 Patients With Amyotrophic Lateral Sclerosis

Pohl, C., Block, W., Karitzky, J., Träber, F., Schmidt, S., Grothe, C., Lamerichs, R. M. J. N., Schild, H. H., & Klockgether, T. (2001) · Archives of Neurology · doi:10.1001/archneur.58.5.729 · Cited by 99 · see citing works

Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla

Baker, E. H., Basso, G., Barker, P. B., Smith, M. A., Bonekamp, D., & Horská, A. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21285 · Cited by 90 · see citing works

GABA-ergic hypotheses of anxiety and depression: Focus on GABA-B receptor

Pilc, A., & Nowak, G. (2005) · Drugs of today · doi:10.1358/dot.2005.41.11.904728 · Cited by 86 · see citing works

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder

Nugent, A. C., Diazgranados, N., Carlson, P. J., Ibrahim, L. A., Luckenbaugh, D. A., Brutsché, N. E., Herscovitch, P., Drevets, W. C., & Zarate, C. A. (2013) · Bipolar Disorders · doi:10.1111/bdi.12118 · Cited by 85 · see citing works

Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression

Papp, M., & Moryl, E. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00675-9 · Cited by 80 · see citing works

Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: A model of sporadic Alzheimer’s disease

Labak, M., Foniok, T., Kirk, D., Rushforth, D., Tomanek, B., Jasiński, A., & Grieb, P. (2010) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-98811-4_32 · Cited by 79 · see citing works

The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test.

Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · PubMed · Cited by 78 · see citing works

Ketamine, magnesium and major depression – From pharmacology to pathophysiology and back

Murck, H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.015 · Cited by 72 · see citing works

Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: A single voxel 1H spectroscopy study

Nery, F. G., Stanley, J. A., Chen, H.-H., Hatch, J. P., Nicoletti, M., Monkul, E. S., Matsuo, K., Caetano, S. C., Peluso, M. A. M., Najt, P., et al. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.05.003 · Cited by 71 · see citing works

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

Taylor, M. J., Tiangga, E. R., Mhuircheartaigh, R. N., & Cowen, P. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111405359 · Cited by 66 · see citing works

Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

Nair, N. P. V., Ahmed, S. K., & Kin, N. M. K. N. Y. (1993) · PubMed · Cited by 65 · see citing works

Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors

Nowak, G., Legutko, B., Skolnick, P., & Popik, P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01589-6 · Cited by 61 · see citing works

Selective Inhibition of Calcium Entry Induced by Benzylisoquinolines in Rat Smooth Muscle

Anselmi, E., Fayos, G., Blasco, R., Candenas, L., Cortés, D., & D’Ocón, P. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb03617.x · Cited by 56 · see citing works

MK-801 and enantiomers: Potential antidepressants or false positives in classical screening models?

Panconi, E., Roux, J., Altenbaumer, M., Hampe, S., & Porsolt, R. D. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90310-p · Cited by 56 · see citing works

Magnesium Intake Is Not Related to Depression Risk in Spanish University Graduates

Derom, M.-L., Martínez‐González, M. Á., Sayón-Orea, M. D. C., Bes‐Rastrollo, M., Beunza, J. J., & Sánchez‐Villegas, A. (2012) · Journal of Nutrition · doi:10.3945/jn.111.155572 · Cited by 50 · see citing works

Polymorphisms in the GAD2 gene‐region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders

Unschuld, P. G., Ising, M., Specht, M., Erhardt, A., Ripke, S., Heck, A., Kloiber, S., Straub, V., Brueckl, T., Müller‐Myhsok, B., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30938 · Cited by 40 · see citing works

Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region

Pilc, A., Brański, P., Pałucha-Poniewiera, A., Tokarski, K., & Bijak, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00169-1 · Cited by 40 · see citing works

Cortical Inhibition, Gamma-Aminobutyric Acid, and Major Depression: There Is Plenty of Smoke but Is There Fire?

Sanacora, G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.003 · Cited by 39 · see citing works

The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats.

Ossowska, G., Klenk-Majewska, B., & Szymczyk, G. (1997) · PubMed · Cited by 38 · see citing works

GABA and affective disorders.

Kg, L., Pl, M., & Bartholini, G. (1987) · PubMed · Cited by 38 · see citing works

Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment

Streeter, C. C., Hennen, J. A., Ke, Y., Jensen, J. E., Sarid‐Segal, O., Nassar, L. E., Knapp, C. M., Meyer, A. A., Kwak, T., Renshaw, P. F., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0121-5 · Cited by 37 · see citing works

Proton MRS and MRSI of the brain without water suppression

Dong, Z. (2014) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2014.12.001 · Cited by 34 · see citing works

The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging

Dorrius, M. D., Pijnappel, R. M., der Weide, M. C. J., Jansen, L., Kappert, P., Oudkerk, M., & Sijens, P. E. (2011) · European Radiology · doi:10.1007/s00330-011-2322-0 · Cited by 32 · see citing works

THE EFFECTS OF MAGNESIUM DEFICIENCY ON KETAMINE SLEEPING TIMES IN THE RAT

Douglas, B., & Dagirmanjian, R. (1975) · British Journal of Anaesthesia · doi:10.1093/bja/47.3.336 · Cited by 29 · see citing works

An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I metabotropic glutamate receptor activation

Zahorodna, A., & Bijak, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00757-8 · Cited by 27 · see citing works

Clinical Handbook for the Management of Mood Disorders

Mann, J., McGrath, P. J., & Roose, S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869 · Cited by 21 · see citing works

Quantification of non–water‐suppressed MR spectra with correction for motion‐induced signal reduction

Lin, J., Tsai, S., Liu, H., Chung, H., Mulkern, R. V., Cheng, C., Yeh, T., & Chen, N. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22119 · Cited by 17 · see citing works

Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation

Silva, S. S. D., Payne, G. S., Morgan, V. A., Ind, T. E. J., Shepherd, J. H., Barton, D. P. J., & deSouza, N. M. (2009) · European Radiology · doi:10.1007/s00330-009-1363-0 · Cited by 16 · see citing works

Correction of frequency and phase variations induced by eddy currents in localized spectroscopy with multiple echo times

Zhang, Y., Marenco, S., & Shen, J. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21265 · Cited by 15 · see citing works

Modulation of the AMPA receptor by phospholipase A2: Effect of the antidepressant trimipramine

Bernard, J., Ohayon, M. M., & Massicotte, G. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90030-2 · Cited by 11 · see citing works

[Proton magnetic resonance spectroscopy of the autistic brain].

Mori, K., Hashimoto, T., Harada, M., Yoneda, Y., Shimakawa, S., Fujii, E., Yamaue, T., Miyazaki, M., Saijo, T., & Kuroda, Y. (2001) · PubMed · Cited by 9 · see citing works

Magnesium intake and depression.

Wilson, K., & Brakoulias, V. (2009) · PubMed · Cited by 8 · see citing works

Ketamine in treatment-resistant depression

Lapidus, K. A. B., & Mathew, S. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.027 · Cited by 4 · see citing works

Quantitative comparison of post‐processing methods for reduction of frequency modulation sidebands in non‐water suppression 1H MRS

Lin, J., Chuang, T., Chung, H., & Tsai, S. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2877 · Cited by 3 · see citing works

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · see citing works

Targeting glutamate signalling in depression: progress and prospects

Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482 · see citing works

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468 · see citing works

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions

Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396 · see citing works

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects

Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0136-3 · Cited by 229 · see citing works

Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study

Pan, J.-X., Xia, J.-J., Deng, F.-L., Liang, W., Wu, J., Yin, B., Dong, M.-X., Chen, J., Ye, F., Wang, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0183-x · Cited by 232 · see citing works

An astroglial basis of major depressive disorder? An overview

Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222 · see citing works

The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.010 · Cited by 219 · see citing works

Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis

Godfrey, K. E. M., Gardner, A. C., Kwon, S., Chea, W., & Muthukumaraswamy, S. D. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.015 · Cited by 207 · see citing works

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22501 · Cited by 206 · see citing works

Fast-acting antidepressant activity of ketamine: Highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies

Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186 · see citing works

Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder

Sarawagi, A., Soni, N. D., & Patel, A. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.637863 · Cited by 172 · see citing works

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy

Dubin, M. J., Mao, X., Banerjee, S., Goodman, Z. T., Lapidus, K. A. B., Kang, G., Liston, C. M., & Shungu, D. C. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150223 · Cited by 156 · see citing works

Role of GABAB receptors in learning and memory and neurological disorders

Heaney, C. F., & Kinney, J. W. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.007 · Cited by 154 · see citing works

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.194 · Cited by 142 · see citing works

Astrocyte, a Promising Target for Mood Disorder Interventions

Zhou, X., Xiao, Q., Xie, L., Yang, F., Wang, L., & Tu, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00136 · Cited by 120 · see citing works

Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment

Abdallah, C. G., Averill, C. L., Salas, R., Averill, L. A., Baldwin, P. R., Krystal, J. H., Mathew, S. J., & Mathalon, D. H. (2017) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.04.006 · Cited by 111 · see citing works

Synaptic Mechanisms Regulating Mood State Transitions in Depression

Parekh, P. K., Johnson, S. B., & Liston, C. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-040422 · Cited by 101 · see citing works

Ketamine for depression

Jelen, L. A., & Stone, J. M. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2020.1854194 · Cited by 102 · see citing works

Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder

Kantrowitz, J. T., Dong, Z., Milak, M. S., Rashid, R., Kegeles, L. S., Javitt, D. C., Lieberman, J. A., & John Mann, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01541-1 · Cited by 100 · see citing works

A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder

Yin, H., Pantazatos, S. P., Galfalvy, H., Huang, Y., Rosoklija, G. B., Dwork, A. J., Burke, A., Arango, V., Oquendo, M. A., & Mann, J. J. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32423 · Cited by 91 · see citing works

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Ionescu, D. F., Felicione, J. M., Gosai, A., Cusin, C., Shin, P., Shapero, B. G., & Deckersbach, T. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000179 · Cited by 91 · see citing works

Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

Hashimoto, K., Bruno, D., Nierenberg, J., Marmar, C. R., Zetterberg, H., Blennow, K., & Pomara, N. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.8 · Cited by 90 · see citing works

Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy

de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Mao, X., León-Ortíz, P., Rodríguez-Mayoral, O., Solís‐Vivanco, R., Favila, R., Graff‐Guerrero, A., & Shungu, D. C. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv105 · Cited by 88 · see citing works

The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Alexander, L., Jelen, L. A., Mehta, M. A., & Young, A. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.003 · Cited by 83 · see citing works

The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity

Kang, M. J. Y., Hawken, E., & Vazquez, G. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.860882 · Cited by 77 · see citing works

Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis

Cao, G., Edden, R. A. E., Gao, F., Li, H., Gong, T., Chen, W., Liu, X., Wang, G., & Zhao, B. (2017) · European Radiology · doi:10.1007/s00330-017-5064-9 · Cited by 76 · see citing works

Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments

Krystal, J., Kaye, A. P., Jefferson, S., Girgenti, M., Wilkinson, S. T., Sanacora, G., & Esterlis, I. (2023) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2305772120 · Cited by 69 · see citing works

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors

da Rosa, P. B., Neis, V. B., Ribeiro, C. M., Moretti, M., & Rodrigues, A. L. S. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.05.010 · Cited by 73 · see citing works

Novel Pharmacological Approaches to the Treatment of Depression

Elias, E., Zhang, A. Y., & Manners, M. T. (2022) · Life · doi:10.3390/life12020196 · Cited by 74 · see citing works

Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients

Abdallah, C. G., Dutta, A., Averill, C. L., McKie, S., Akiki, T. J., Averill, L. A., & William Deakin, J. F. (2018) · Chronic Stress · doi:10.1177/2470547018796102 · Cited by 70 · see citing works

Brain γ‐aminobutyric acid (GABA) detection in vivo with the J‐editing 1H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test–retest reliability

Shungu, D. C., Mao, X., Gonzales, R., Soones, T. N., Dyke, J. P., van der Veen, J. W. C., & Kegeles, L. S. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3539 · Cited by 70 · see citing works

Stress-Related Dysfunction of Adult Hippocampal Neurogenesis—An Attempt for Understanding Resilience?

Leschik, J., Lutz, B., & Gentile, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147339 · Cited by 70 · see citing works

Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

Li, M., Demenescu, L. R., Čolić, L., Metzger, C. D., Heinze, H., Steiner, J. H., Speck, O., Fejtová, A., Salvadore, G., & Walter, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.184 · Cited by 66 · see citing works

Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex

Woelfer, M., Li, M., Colic, L., Liebe, T., Di, X., Biswal, B., Murrough, J., Lessmann, V., Brigadski, T., & Walter, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1679391 · Cited by 64 · see citing works

Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial

Milak, M. S., Rashid, R., Dong, Z., Kegeles, L. S., Grunebaum, M. F., Ogden, R. T., Lin, X., Mulhern, S. T., Suckow, R. F., Cooper, T. B., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13211 · Cited by 63 · see citing works

In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept

Rodríguez, C. I., Kegeles, L. S., Levinson, A. R., Ogden, R. T., Mao, X., Milak, M. S., Vermes, D., Xie, S., Hunter, L. E., Flood, P. D., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.001 · Cited by 61 · see citing works

Cortical functional hyperconnectivity in a mouse model of depression and selective network effects of ketamine

McGirr, A., LeDue, J. M., Chan, A. W., Xie, Y., & Murphy, T. H. (2017) · Brain · doi:10.1093/brain/awx142 · Cited by 58 · see citing works

Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy

Levitt, J. G., Kalender, G., O’Neill, J., Diaz‐Fong, J. P., Cook, I. A., Ginder, N. D., Krantz, D. E., Minzenberg, M., Vince-Cruz, N., Nguyen, L. D., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180230 · Cited by 59 · see citing works

NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research

Lv, S., Yao, K., Zhang, Y., & Zhu, S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109378 · Cited by 57 · see citing works

JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stress

Zhu, X., Nedelcovych, M. T., Thomas, A. G., Hasegawa, Y., Moreno-Megui, A., Coomer, W., Vohra, V., Saito, A., Perez, G., Wu, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0177-7 · Cited by 53 · see citing works

Default mode network connectivity change corresponds to ketamine’s delayed glutamatergic effects

Li, M., Woelfer, M., Čolić, L., Safron, A., Chang, C. E., Heinze, H., Speck, O., Mayberg, H. S., Biswal, B. B., Salvadore, G., et al. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0942-y · Cited by 57 · see citing works

7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study

Evans, J. W., Lally, N., An, L., Li, N., Nugent, A. C., Banerjee, D., Snider, S. L., Shen, J., Roiser, J. P., & Zarate, C. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0057-1 · Cited by 53 · see citing works

The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression

Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49 · see citing works

Glutamate quantification by PRESS or MEGA-PRESS: Validation, repeatability, and concordance

van Veenendaal, T. M., Backes, W. H., van Bussel, F. C. G., Edden, R. A. E., Puts, N. A. J., Aldenkamp, A. P., & Jansen, J. F. A. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2017.12.029 · Cited by 50 · see citing works

The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants

Yin, Y., Wang, Y., Liu, W., Yao, J.-Q., Yuan, J., Li, Z.-H., Ran, Y., Zhang, L., & Li, Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108573 · Cited by 48 · see citing works

Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram

Brennan, B. P., Admon, R., Perriello, C., LaFlamme, E. M., Athey, A. J., Pizzagalli, D. A., Hudson, J. I., Pope, H. G., & Jensen, J. E. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.08.009 · Cited by 47 · see citing works

Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies

Medeiros, G. C., Matheson, M., Demo, I., Reid, M. J., Matheson, S., Twose, C., Smith, G. S., Gould, T. D., Zarate, C. A., Barrett, F. S., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00183-9 · Cited by 49 · see citing works

Managing Negative Symptoms of Schizophrenia: How Far Have We Come?

Kantrowitz, J. T. (2017) · CNS Drugs · doi:10.1007/s40263-017-0428-x · Cited by 43 · see citing works

Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study

Silberbauer, L., Spurny‐Dworak, B., Handschuh, P. A., Klöbl, M., Bednařík, P., Reiter, B., Ritter, V., Trost, P., Konadu, M. E., Windpassinger, M., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.549903 · Cited by 42 · see citing works

Ketamine metabolite pilot study in a suicidal depression trial

Grunebaum, M. F., Galfalvy, H. C., Choo, T.-H., Parris, M. S., Burke, A. K., Suckow, R. F., Cooper, T. B., & Mann, J. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.005 · Cited by 41 · see citing works

Estimating glutamate and Glx from GABA-optimized MEGA-PRESS: Off-resonance but not difference spectra values correspond to PRESS values

Maddock, R. J., Caton, M., & Ragland, J. D. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.07.003 · Cited by 41 · see citing works

Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study

Jelen, L. A., Lythgoe, D. J., Stone, J. M., Young, A. H., & Mehta, M. A. (2025) · Nature Medicine · doi:10.1038/s41591-025-03800-w · Cited by 41 · see citing works

Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex

Sala, N., Paoli, C., Bonifacino, T., Mingardi, J., Schiavon, E., Via, L. L., Milanese, M., Tornese, P., Datusalia, A. K., Rosa, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.759626 · Cited by 38 · see citing works

The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug

Pałucha-Poniewiera, A. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.02.011 · Cited by 36 · see citing works

Neurobiological biomarkers of response to ketamine

Kadriu, B., Ballard, E. D., Henter, I. D., Murata, S., Gerlus, N., & Zarate, C. A. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.003 · Cited by 36 · see citing works

Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses

Fogaça, M. V., Daher, F., & Picciotto, M. R. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02002-1 · Cited by 34 · see citing works

Recent advances in the biosensing of neurotransmitters: material and method overviews towards the biomedical analysis of psychiatric disorders

Mobed, A., Hasanzadeh, M., Ahmadalipour, A., & Fakhari, A. (2019) · Analytical Methods · doi:10.1039/c9ay02390a · Cited by 35 · see citing works

Associations Between Disordered Microbial Metabolites and Changes of Neurotransmitters in Depressed Mice

Xie, J., Wang, Y., Zhong, Q., Bai, S., Zhou, C., Tian, T., & Chen, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.906303 · Cited by 33 · see citing works

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Bojesen, K. B., Andersen, K. A., Rasmussen, S. N., Baandrup, L., Madsen, L. M., Glenthoj, B. Y., Rostrup, E., & Broberg, B. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00022 · Cited by 31 · see citing works

Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy

Zhang, N., Zhang, Y., Wang, Z., & Chen, N. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00861-2 · Cited by 31 · see citing works

The potential of 1H-MRS in CNS drug development

Egerton, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05344-7 · Cited by 30 · see citing works

Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review

Gonsalves, M. A., White, T. L., Barredo, J., Fukuda, A. M., Joyce, H. E., Harris, A. D., & Carpenter, L. L. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103049 · Cited by 29 · see citing works

Cortical excitatory and inhibitory correlates of the fronto-limbic circuit in major depression and differential effects of left frontal brain stimulation in a randomized sham-controlled trial

Li, C., Juan, C.-H., Lin, H., Cheng, C., Wu, H.-T., Yang, B., Tsai, S., Su, T., & Fitzgerald, P. B. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.107 · Cited by 30 · see citing works

Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review

Demchenko, I., Tassone, V. K., Kennedy, S. H., Dunlop, K., & Bhat, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864902 · Cited by 29 · see citing works

Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine

Zavaliangos‐Petropulu, A., Al‐Sharif, N., Taraku, B., Leaver, A. M., Sahib, A. K., Espinoza, R. T., & Narr, K. L. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.11.005 · Cited by 28 · see citing works

Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control

Höflich, A. S., Ganger, S., Tik, M., Hahn, A., Kranz, G. S., Vanicek, T., Spies, M., Kraus, C., Windischberger, C., Kasper, S. F., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.032 · Cited by 26 · see citing works

Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression

Hochschild, A., Keilp, J. G., Madden, S. P., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.055 · Cited by 25 · see citing works

Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders

Ali, D. N., Ali, H. M., Lopez, M. R., Kang, S., & Choi, D. (2024) · Cells · doi:10.3390/cells13040318 · Cited by 26 · see citing works

A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression

Joseph, B., Parsaik, A. K., Ahmed, A. T., Erwin, P. J., & Singh, B. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001317 · Cited by 26 · see citing works

Network-Guided Transcranial Magnetic Stimulation for Depression

Dubin, M. J., Liston, C. M., Avissar, M., Ilieva, I. P., & Gunning, F. M. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0108-7 · Cited by 25 · see citing works

Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles

Stenovec, M., Božić, M., Pirnat, S., & Zorec, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02744-1 · Cited by 25 · see citing works

Predicting Antidepressant Effects of Ketamine: the Role of the Pregenual Anterior Cingulate Cortex as a Multimodal Neuroimaging Biomarker

Weigand, A., Gärtner, M., Scheidegger, M., Wyss, P. O., Henning, A., Seifritz, E., Stippl, A., Herrera-Meléndez, A. L., Bajbouj, M., Aust, S., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac049 · Cited by 22 · see citing works

Imaging TMS: antidepressant mechanisms and treatment optimization

Dubin, M. J. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1283297 · Cited by 22 · see citing works

Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cycling

Veldić, M., Millischer, V., Port, J. D., Ho, A. M., Jia, Y., Geske, J. R., Biernacka, J. M., Backlund, L., McElroy, S. L., Bond, D. J., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0483-9 · Cited by 23 · see citing works

d -Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine

Kantrowitz, J. T., Milak, M. S., Mao, X., Shungu, D. C., & Mann, J. J. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16060735 · Cited by 21 · see citing works

Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders

Haroon, E., & Miller, A. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470805 · Cited by 21 · see citing works

Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study

Huang, L.-C., Lin, S.-H., Tseng, H.-H., Chen, K. C., Abdullah, M., & Yang, Y. K. (2022) · Psychological Medicine · doi:10.1017/s003329172100533x · Cited by 20 · see citing works

Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings

Boucherie, D. E., Reneman, L., Ruhé, H. G., & Schrantee, A. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103517 · Cited by 20 · see citing works

Ketamine and ECT: better alone than together?

Kellner, C. H., & Iosifescu, D. V. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30099-8 · Cited by 19 · see citing works

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

Fagerholm, E. D., Leech, R., Williams, S., Zarate, C. A., Moran, R., & Gilbert, J. R. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01442-3 · Cited by 18 · see citing works

A reappraisal of the mechanisms of action of ketamine to treat complex regional pain syndrome in the light of cortical excitability changes

Sorel, M., Zrek, N., Locko, B., Armessen, C., Ayache, S. S., & Lefaucheur, J. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.02.124 · Cited by 18 · see citing works

A preliminary study of the association of increased anterior cingulate gamma-aminobutyric acid with remission of depression after ketamine administration

Singh, B., Port, J. D., Voort, J. L. V., Coombes, B. J., Geske, J. R., Lanza, I. R., Morgan, R. J., & Frye, M. A. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113953 · Cited by 18 · see citing works

A role of GABAA receptor α1 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine

Tang, X.-H., Diao, Y.-G., Ren, Z.-Y., Zang, Y., Zhang, G.-F., Wang, X., Duan, G., Shen, J.-C., Hashimoto, K., Zhou, Z., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109383 · Cited by 18 · see citing works

Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect

Stenovec, M. (2021) · Life · doi:10.3390/life11060573 · Cited by 17 · see citing works

Functional MRI markers for treatment-resistant depression: Insights and challenges

Kotoula, V., Evans, J. W., Punturieri, C., Johnson, S. C., & Zarate, C. A. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.04.001 · Cited by 17 · see citing works

Ketamine and Esketamine for Depression in Daily Practice

Singh, B. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001898 · Cited by 17 · see citing works

Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot Study

Bhattacharyya, P. K., Anand, A., Lin, J. Y., & Altinay, M. I. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.665347 · Cited by 16 · see citing works

Antidepressant Response and Stress Resilience Are Promoted by CART Peptides in GABAergic Neurons of the Anterior Cingulate Cortex

Funayama, Y., Li, H., Ishimori, E., Kawatake-Kuno, A., Inaba, H., Yamagata, H., Seki, T., Nakagawa, S., Watanabe, Y., Murai, T., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.009 · Cited by 16 · see citing works

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder

Liu, H., Wang, C., Lan, X., Li, W., Zhang, F., Fu, L., Ye, Y., Ning, Y., & Zhou, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1123797 · Cited by 15 · see citing works

Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects

Čolić, L., McDonnell, C., Li, M., Woelfer, M., Liebe, T., Kretzschmar, M., Speck, O., Schott, B. H., Bianchi, M., & Walter, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.021 · Cited by 15 · see citing works

Antidepressant-like Effects of Representative Types of Food and Their Possible Mechanisms

Piao, J., Wang, Y., Zhang, T., Zhao, J., Lv, Q., Ruan, M., Yu, Q., & Li, B. (2023) · Molecules · doi:10.3390/molecules28196992 · Cited by 15 · see citing works

The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?

Frizzo, M. E. (2019) · Current Therapeutic Research · doi:10.1016/j.curtheres.2019.100566 · Cited by 16 · see citing works

Glutamate-Based Drug Discovery for Novel Antidepressants

Pałucha-Poniewiera, A., & Pilc, A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1213234 · Cited by 14 · see citing works

Neurochemical correlates of behavioral treatment of pediatric trichotillomania

Peris, T. S., Piacentini, J. C., Vreeland, A., Salgari, G. C., Levitt, J. G., Alger, J., Posse, S., McCracken, J. T., & O’Neill, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.061 · Cited by 13 · see citing works

Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism

Gärtner, M., Weigand, A., Scheidegger, M., Lehmann, M., Wyss, P. O., Wunder, A., Henning, A., & Grimm, S. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01377-2 · Cited by 13 · see citing works

NMDA Antagonists for Treatment-Resistant Depression

Farber, N. B. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_165 · Cited by 13 · see citing works

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study

Dong, Z., Grunebaum, M. F., Lan, M. J., Wagner, V., Choo, T.-H. J., Milak, M. S., Sobeih, T. M., Mann, J. J., & Kantrowitz, J. T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.653026 · Cited by 12 · see citing works

The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies

Jiang, Y., Dong, Y., & Hu, H. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0225 · Cited by 11 · see citing works

Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder

Gärtner, M., de Rover, M., Václavů, L., Scheidegger, M., van Osch, M. J. P., & Grimm, S. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2020900 · Cited by 11 · see citing works

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression

Salvadore, G., van der Veen, J. W. C., Zhang, Y., Marenco, S., Machado‐Vieira, R., Baumann, J., Ibrahim, L. A., Luckenbaugh, D. A., Shen, J., Drevets, W. C., et al. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001593 · Cited by 107 · see citing works

Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression

Njau, S. N., Zavaliangos‐Petropulu, A., Joshi, S. H., Brooks, J. O., O'Neill, J., Roger, W. P., Norris, V., Espinoza, R. T., & Narr, K. L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70102 · Cited by 2 · see citing works

Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial

Milak, M. S., Rashid, R., Dong, Z., Kegeles, L. S., Grunebaum, M. F., Ogden, R. T., Lin, X., Mulhern, S. T., Suckow, R. F., Cooper, T. B., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13211 · Cited by 63 · see citing works

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

Taylor, M. J., Tiangga, E. R., Mhuircheartaigh, R. N., & Cowen, P. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111405359 · Cited by 66 · see citing works

Acute ketamine administration modulates glutamatergic neurotransmission and functional brain activation in prefrontal cortex implications for major depression

Scheidegger, M., Henning, A., Walter, M., Fuchs, A., Krähenmann, R., Böker, H., Boesiger, P., Seifritz, E., & Grimm, S. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1292539